Visitors to the Marco booth #1311 at this year's American Society ofCataract and Refractive Surgery (ASCRS) annual meeting are witness to anew technology that makes it possible to reduce refraction time to as littleas 30 seconds.
From waste to wonder: Transformational advances in scleral allograft technology
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Iantrek announces 1-year clinical results of its bio-interventional technology for uveoscleral outflow enhancement in open-angle glaucoma patients
Advancing the optimal diagnosis & treatment of thyroid eye disease
ANI Pharmaceuticals completes acquisition of Alimera Sciences
Expanding the range of vision with monofocal IOLs